Stockpickr! Your Source for Stock Ideas

Blogs about BLTI

Blogs	Description	Date Updated
Biolase Tech (BLTI) Sees Insider Buying	Visit StreetInsider.com at http://www.streetinsider.com/Insider+Trades/Biolase+Tech+%28BLTI%29+Sees+Insider+Buying/3648618.html for the full story....	May 14, 2008
Thursday's Upgrades and Downgrades	UpgradesTaiwan Semi (TSM)- Lehman Brothers Equal-weight » Overweight Regions Fincl (RF)- Stifel Nicolaus Sell » Hold Biolase Technology (BLTI)- FTN Midwest Neutral » Buy Mine Safety (MSA)- Friedman Billings Mkt Perform » Outperform Pioneer Drilling (PDC)- Deutsche Securities Hold » Buy Omniture (OMTR)- Jefferies & Co Hold » Buy Plains Exploration (PXP)- Credit Suisse Neutral » Outperform Obagi Medical (OMPI)- Oppenheimer Perform » OutperformPanacos Phar...	March 06, 2008
Unusual 11 Mid-Day Movers 1/07: BLTI, EBS, ITMN Higher; SHOR, AVCT, CSUN, SLM Lower	ShoreTel, Inc. (Nasdaq: SHOR) 46% LOWER; expects Q2 revenue to be in the range of $29.7 to $30.7 million, lower than its previous expectation of $32 to $35 million. The Wall Street consensus is $34.1 million. The company said, "Our preliminary review indicates that sales to existing customers grew during the quarter, however, sales to new customers declined." BIOLASE Technology, Inc. (NASDAQ: BLTI) 37.5% HIGHER; has named Jake St. Philip as Chief Executive Officer of the Company and as a memb...	January 07, 2008
Pre-Open Movers: ShoreTel (SHOR), ev3 (EVVV), Avocent (AVCT) Down On Guidance; SLM (SLM) Up On New Appointments	StreetInsider.com Pre-Open Movers: BIOLASE Technology, Inc. (NASDAQ: BLTI) 30% HIGHER; has named Jake St. Philip as Chief Executive Officer of the Company and as a member of its Board of Directors. Separately, BIOLASE expects to report net revenue of greater than $20 million for the fourth quarter ended December 31, 2007, the highest level of quarterly revenue recorded to date at BIOLASE. Revenue is estimated to have rebounded from $12.8 million in the 2007 third quarter and also should comp...	January 07, 2008
StreetInsider.com Unusual 11 Mid-Day Movers 04/11/2007	BIOLASE Technology (Nasdaq: BLTI) 23% LOWER; Expects to report net revenue in the range of $14.5 million to $15.0 million and a net loss for the first quarter ended March 31, 2007. (Consensus is $18.58 million) Methode Electronics (Nasdaq: METH) 15% LOWER; Baird downgrades METH from Neutral to Underperform, saying the company's opportunities are already priced in the stock. Nuvelo Inc. (Nasdaq: NUVO) 14% LOWER; Stock giving some back after moving up over 50% in the past few trading session...	April 11, 2007
StreetInsider.com Pre-Open Movers 04/11	StreetInsider.com Pre-Open Movers: Cell Therapeutics, Inc. (Nasdaq: CTIC) 19% HIGHER; announced today that XYOTAX, a novel biologically- enhanced version of one of the most used cancer drugs, Taxol, qualifies for fast track designation for the treatment of PS2. BIOLASE Technology, Inc. (Nasdaq: BLTI) 17.8% LOWER; expects to report net revenue in the range of $14.5 million to $15.0 million and a net loss for the first quarter ended March 31, 2007. (Consensus is $18.58 million) American M...	April 11, 2007
Festival of Stocks #31	Welcome to the 31st edition of the Festival of Stocks. The Festival of Stocks is a blog carnival dedicated to highlighting bloggers best posts on stock market related topics. This is my sixth time hosting the Festival of Stocks here at Fat Pitch Financials, the birth place of this online weekly event. I want to thank everyone for making my idea for the Festival of Stocks become reality. The home of the Festival of Stocks at Value Investing News has evolved quite a bit since I first launched the...	April 09, 2007

Enter search text here: